Catalysts for ViiV Healthcare Company
93 tracked
Nov 26, 2025
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Oct 28, 2025
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 28, 2025
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 28, 2025
approval
TRIUMEQ PD (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Oct 28, 2025
approval
TIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 28, 2025
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 28, 2025
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Apr 11, 2025
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Sep 20, 2024
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Apr 18, 2024
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 18, 2024
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 18, 2024
approval
TRIUMEQ PD (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Apr 18, 2024
approval
TIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 18, 2024
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 18, 2024
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Apr 5, 2024
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 5, 2024
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Dec 13, 2023
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Nov 3, 2023
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jun 15, 2023
approval
TRIUMEQ PD (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Jun 15, 2023
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Feb 27, 2023
approval
CABENUVA KIT (CABOTEGRAVIR) — FDA approval
ViiV Healthcare Company
→
Jan 25, 2023
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 7, 2022
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 7, 2022
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 7, 2022
approval
TRIUMEQ PD (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Oct 7, 2022
approval
TIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 7, 2022
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Oct 7, 2022
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Mar 30, 2022
approval
TRIUMEQ PD (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→